The analysis of our results suggests relationships between glutamine (Gln), pyroglutamate (PGlu), and alpha ERD during cognitive challenges as prominent interests distinguishing cognitively healthy older adults with minimal risk (CH-NAT) from those with elevated risk (CH-PAT) of cognitive decline. The gene discussed is BRD2; the disease is Mental deterioration.